189 related articles for article (PubMed ID: 29273470)
1. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.
Li WY; Yu G; Hogan RM; Mohandas R; Frye RF; Gumpricht E; Markowitz JS
Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
3. Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
Méndez-Sánchez N; Dibildox-Martinez M; Sosa-Noguera J; Sánchez-Medal R; Flores-Murrieta FJ
BMC Pharmacol Toxicol; 2019 Jan; 20(1):5. PubMed ID: 30635055
[TBL] [Abstract][Full Text] [Related]
4. Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin.
Savio D; Harrasser PC; Basso G
Arzneimittelforschung; 1998 Nov; 48(11):1104-6. PubMed ID: 9850434
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of silibinin in healthy male volunteers.
Kim YC; Kim EJ; Lee ED; Kim JH; Jang SW; Kim YG; Kwon JW; Kim WB; Lee MG
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):593-6. PubMed ID: 14692709
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
7. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
8. Absorption and metabolism of milk thistle flavanolignans in humans.
Calani L; Brighenti F; Bruni R; Del Rio D
Phytomedicine; 2012 Dec; 20(1):40-6. PubMed ID: 23072776
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
[TBL] [Abstract][Full Text] [Related]
11. Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry.
Lee JI; Hsu BH; Wu D; Barrett JS
J Chromatogr A; 2006 May; 1116(1-2):57-68. PubMed ID: 16631762
[TBL] [Abstract][Full Text] [Related]
12. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
Woo JS; Kim TS; Park JH; Chi SC
Arch Pharm Res; 2007 Jan; 30(1):82-9. PubMed ID: 17328246
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
Barzaghi N; Crema F; Gatti G; Pifferi G; Perucca E
Eur J Drug Metab Pharmacokinet; 1990; 15(4):333-8. PubMed ID: 2088770
[TBL] [Abstract][Full Text] [Related]
15. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
[TBL] [Abstract][Full Text] [Related]
16. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of silibinin in horses.
Hackett ES; Mama KR; Twedt DC; Gustafson DL
Am J Vet Res; 2013 Oct; 74(10):1327-32. PubMed ID: 24066917
[TBL] [Abstract][Full Text] [Related]
18. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
Xu D; Ni R; Sun W; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
[TBL] [Abstract][Full Text] [Related]
19. A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma.
Brinda BJ; Zhu HJ; Markowitz JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():1-9. PubMed ID: 22766231
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles.
Yu JN; Zhu Y; Wang L; Peng M; Tong SS; Cao X; Qiu H; Xu XM
Acta Pharmacol Sin; 2010 Jun; 31(6):759-64. PubMed ID: 20523347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
